Big Themes
Our academic conference, TRANSLATION 2023, is an opportunity to hear about new developments in dementia research and join discussions about big data, biomarkers and trials delivery – all of which can lead to new disease-modifying treatments for dementia.
DON'T FORGET TO REGISTER FOR THE CONFERENCE
Biomarkers for Dementia Research
Imaging and blood-based biomarkers have the potential to improve the accuracy by which specific causes of dementia can be diagnosed and cured. This is an evolving field, with numerous potential biomarkers in varying stages of research and development.
Translation 2023 seeks to review currently available biomarkers for the most common forms of neurodegenerative dementia, and gives an overview of research techniques that may in due course make their way into the clinic.
Keynote Speaker
Janssen: Biomarkers and drugs development
Session Speakers
Professor Dame Pamela Shaw: University of Sheffield Developing biomarkers for Motor Neuron Disease
Professor Sarah Tabrizi: University College London From basic science to novel therapies by collaboration
Professor Masud Husain: University of Oxford Development of biomarkers in dementia translation
Big Data for Advancing Dementia Research
Dementia is increasing in prevalence and to date has no cure or treatment. One element in improving this situation is using and sharing data more widely to increase the power of research.
Translation 2023 seeks to explore data sharing initiatives and practices in dementia research in order to recommend next steps moving forward.
Keynote Speakers
SV Investors Opportunities for innovative collaboration
Professor Sir Menelas Pangalos
Astra Zeneca
Session Speakers
Dr Ruth McKernan: Venture Partner at SV Investors
Professor Mihaela van Schaar: Alan Turing Institute Machine learning and big data in dementia
Professor Paul Matthews: Imperial College London From ‘omics to linkage in dementia
Trials Delivery in Dementia
Barriers to recruitment for dementia studies are well documented. Trials delivery establishes an engine for testing new treatments for dementia to bring the right people to the right place for the right project.
Translation 2023 will explore latest developments in implementation and outcomes of dementia research registry in the UK, further discuss existing interventions to understand study participants in clinical registries and referrals.
Keynote Speaker
University of Nevada Las Vegas The dementia drug development pipeline
Session Speakers
Professor Cornelia van Duijn: University of Oxford Genetics for dementia trials
Professor Julian Matthews: University of Manchester PET/MR for dementia trials
Professor Richard Haynes: University of Oxford The Recovery Trial, a new paradigm for dementia trials
Professor David Burn: University of Newcastle Optimising UK trials infrastructure